Skip to search formSkip to main contentSkip to account menu

CER-001

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2018
Highly Cited
2018
Importance CER-001 is a negatively charged, engineered pre-&bgr; high-density lipoprotein (HDL) mimetic containing apolipoprotein… 
2017
2017
BACKGROUND CER-001 is an engineered pre-beta high-density lipoprotein (HDL) mimetic, which rapidly mobilizes cholesterol… 
2017
2017
BACKGROUND High-density lipoprotein (HDL) is believed to have atheroprotective properties, but an effective HDL-based therapy… 
Highly Cited
2016
Highly Cited
2016
Highly Cited
2015
Highly Cited
2015
Reverse cholesterol transport (RCT) contributes to the anti-atherogenic effects of HDL. Patients with the orphan disease… 
2015
2015
Objective CER-001 is a novel engineered HDL-mimetic comprised of recombinant human apoA-I and charged phospholipids that was… 
Highly Cited
2014
Highly Cited
2014
Aim High-density lipoproteins (HDLs) have several potentially protective vascular effects. Most clinical studies of therapies… 
Review
2013
Review
2013
Familial hypercholesterolaemia (FH) is an autosomal dominant genetic disorder, associated with elevated levels of low-density… 
2011
2011
Background: CER-001 is a synthetic HDL, comprised of recombinant human ApoA-I complexed with phospholipids and designed to mimic…